Celularity INC (CELUW) — 8-K Filings

All 8-K filings from Celularity INC. Browse 36 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (36)

Celularity Inc. Files 8-K: Material Agreements and Equity Sales — Dec 23, 2025 Risk: medium
On December 19, 2025, Celularity Inc. entered into a material definitive agreement and incurred a direct financial obligation. The company also reported unregis
Celularity Inc. Files 8-K on Security Holder Vote Matters — Dec 19, 2025 Risk: medium
Celularity Inc. filed an 8-K on December 19, 2025, reporting on the submission of matters to a vote of security holders. The company, formerly GX Acquisition Co
8-K Filing — Dec 5, 2025
Celularity Inc. Files 8-K: Material Agreements & Equity Sales — Oct 28, 2025 Risk: medium
Celularity Inc. entered into a material definitive agreement on October 24, 2025. The company also reported on unregistered sales of equity securities and amend
Celularity Inc. Files 8-K Under 'Other Events' — Sep 3, 2025 Risk: low
Celularity Inc. filed an 8-K on September 3, 2025, reporting an event on September 2, 2025. The filing is categorized under 'Other Events' and does not specify
Celularity Inc. Files 8-K: Material Definitive Agreement — Aug 18, 2025 Risk: medium
Celularity Inc. entered into a Material Definitive Agreement on August 13, 2025. The filing also includes other events and financial statements/exhibits. Celula
Celularity Inc. Files 8-K: Material Definitive Agreement — Aug 12, 2025 Risk: medium
Celularity Inc. entered into a material definitive agreement on August 5, 2025. The company, formerly known as GX Acquisition Corp., is incorporated in Delaware
Celularity Inc. Files 8-K: Material Agreement & Equity Sales — Aug 1, 2025 Risk: medium
On July 21, 2025, Celularity Inc. entered into a material definitive agreement, likely related to its financial obligations. The company also reported on the cr
Celularity Inc. Files 8-K on Material Agreement and Equity Sales — Jul 30, 2025 Risk: medium
Celularity Inc. filed an 8-K on July 30, 2025, reporting on events that occurred on July 14, 2025. The filing indicates an entry into a material definitive agre
Celularity Inc. Files 8-K for Material Agreement — Jul 22, 2025 Risk: medium
Celularity Inc. entered into a material definitive agreement on June 23, 2025, related to unregistered sales of equity securities. The filing also includes fina
Celularity Inc. Files 8-K: Board Changes & Compensation Updates — Jun 10, 2025 Risk: medium
Celularity Inc. announced on June 10, 2025, changes in its board of directors and executive compensation arrangements. The filing also includes financial statem
Celularity Inc. Reports Board and Executive Compensation Changes — Jun 6, 2025 Risk: medium
Celularity Inc. announced on June 5, 2025, a change in its board of directors and executive compensation arrangements. Specifically, the company reported the de
Celularity Inc. Files 8-K on Material Agreements — May 20, 2025 Risk: medium
On May 20, 2025, Celularity Inc. filed an 8-K report detailing a material definitive agreement and unregistered sales of equity securities. The company, formerl
Celularity Inc. Announces Board and Executive Compensation Changes — May 16, 2025 Risk: medium
Celularity Inc. announced on May 14, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certai
Celularity Inc. Files 8-K on Financials — May 9, 2025 Risk: low
Celularity Inc. filed an 8-K on May 9, 2025, reporting on its results of operations and financial condition, and providing financial statements and exhibits. Th
Celularity Inc. Updates Principal Executive Offices — May 1, 2025 Risk: low
Celularity Inc. filed an 8-K on May 1, 2025, reporting an event on April 30, 2025. The filing indicates a change in the company's principal executive offices to
Celularity Inc. Faces Delisting Concerns — Apr 23, 2025 Risk: high
Celularity Inc. filed an 8-K on April 23, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The earliest event reported was
Celularity Inc. Files 8-K for Material Agreement — Mar 21, 2025 Risk: medium
On March 17, 2025, Celularity Inc. entered into a material definitive agreement related to unregistered sales of equity securities. The company, formerly known
Celularity Inc. Files 8-K Report — Feb 24, 2025 Risk: low
Celularity Inc. filed an 8-K on February 24, 2025, reporting other events and financial statements. The company, previously known as GX Acquisition Corp., is in
Celularity Inc. Files 8-K: Material Agreement & Equity Sales — Feb 18, 2025 Risk: medium
Celularity Inc. entered into a material definitive agreement on February 12, 2025. The company also reported on unregistered sales of equity securities and file
Celularity Inc. Enters Material Definitive Agreement — Jan 27, 2025 Risk: medium
Celularity Inc. entered into a material definitive agreement on January 24, 2025. The company, formerly known as GX Acquisition Corp., is incorporated in Delawa
Celularity Inc. Terminates Material Definitive Agreement — Jan 24, 2025 Risk: medium
Celularity Inc. announced on January 23, 2025, the termination of a material definitive agreement. The company, formerly known as GX Acquisition Corp., is incor
Celularity Inc. Files 8-K for Material Agreement — Jan 3, 2025 Risk: medium
Celularity Inc. entered into a material definitive agreement on December 27, 2024, related to unregistered sales of equity securities. The company, formerly GX
Celularity Inc. Holds Stockholder Meeting — Dec 20, 2024 Risk: low
Celularity Inc. announced on December 19, 2024, that it held a special meeting of its stockholders. The primary purpose of this meeting was to vote on proposals
Celularity Inc. Files 8-K for Material Agreement and Equity Sales — Dec 2, 2024 Risk: medium
On November 25, 2024, Celularity Inc. entered into a material definitive agreement, creating a direct financial obligation. The company also reported on the unr
Celularity Receives Nasdaq Delisting Warning — Nov 29, 2024 Risk: high
Celularity Inc. received a notice on November 21, 2024, indicating it failed to meet the continued listing rule standards for The Nasdaq Stock Market LLC. The c
Celularity Inc. Files 8-K: Other Event Reported — Nov 8, 2024 Risk: medium
Celularity Inc. filed an 8-K on November 8, 2024, reporting an "Other Event." The filing does not contain specific details about the event, dollar amounts, or d
Celularity Inc. Files 8-K on Financials and Other Events — Nov 7, 2024 Risk: medium
Celularity Inc. filed an 8-K on November 7, 2024, reporting on its financial condition and other events. The filing includes financial statements and exhibits,
Celularity Inc. Files 8-K on Financials — Oct 25, 2024 Risk: medium
Celularity Inc. filed an 8-K on October 25, 2024, reporting on its results of operations and financial condition as of October 22, 2024. The filing includes fin
Celularity Faces Nasdaq Delisting Notice — Oct 21, 2024 Risk: high
Celularity Inc. received a notice of delisting or failure to satisfy continued listing rules from the Nasdaq Stock Market on October 18, 2024. The company is cu
Celularity Inc. Files 8-K: Material Definitive Agreement — Oct 16, 2024 Risk: medium
On October 9, 2024, Celularity Inc. entered into a material definitive agreement. The company, formerly known as GX Acquisition Corp., is incorporated in Delawa
Celularity CEO & Chairman Resigns, New Leadership Appointed — Sep 13, 2024 Risk: medium
Celularity Inc. announced on July 24, 2024, a change in its board of directors. Specifically, Dr. Robert J. Hariri has resigned from his position as Chief Execu
Celularity Inc. Announces CEO Change and Board Appointments — Aug 28, 2024 Risk: medium
Celularity Inc. announced on August 27, 2024, several key executive and board changes. Dr. Robert J. Hariri has stepped down as Chief Executive Officer and will
Celularity Inc. Faces Delisting Notice — Aug 23, 2024 Risk: high
Celularity Inc. received a notice on August 22, 2024, indicating it failed to meet a continued listing rule or standard for its stock. This filing is a Form 8-K
Celularity Changes Auditors Amidst Audit Scope Disagreement — Aug 5, 2024 Risk: medium
Celularity Inc. announced on July 31, 2024, the departure of its independent registered public accounting firm, WithumSmith+Brown, PC. The company has appointed
Celularity Faces Nasdaq Delisting Notice — May 24, 2024 Risk: high
Celularity Inc. received a notice on May 21, 2024, indicating it failed to meet the continued listing standards of the Nasdaq Capital Market. The company is cur

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX